Enterome Is A Clinical Stage Biopharmaceutical Company Based In Parisfrancefounded In 2012The Company Focuses On Developing Innovative Therapeutic Solutionsparticularly Immunomodulatory Drugs For Cancer And Immune Diseasesenterome Leverages The Interaction Between The Gut Microbiome And The Immune System To Identify Novel Therapeutics The Company Utilizes A Drug Discovery Platform Called Mimicrywhich Employs Biocomputational Tools And Bioassays To Discover Potential Drugs From A Vast Database Of Gut Microbiome Proteinsenterome S Product Pipeline Includes Candidates Like Eo2463 For Non Hodgkin Lymphomaseo2401 For Glioblastoma And Adrenal Tumorsand Eo4010 For Colorectal Cancertheir Oncomimics Approach Aims To Generate A Strong Immune Response By Utilizing The Patient S Own T Cells With Over A 135 Million Raised In Funding And A Team Of Approximately 70 Employeesenterome Is Advancing Its Research And Development Efforts Through Collaborations And A Strong Intellectual Property Portfolio
No conferences found for this company.
| Company Name | Enterome Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
